奥特奇蒙药董事长向公伟: 全产业链布局 推动蒙医药理论标准化
Zhong Guo Zheng Quan Bao·2025-05-05 20:40

Core Insights - The company has achieved a 40-fold growth in sales over the past decade, establishing itself as a leader in the Mongolian medicine industry [1][3] - The company employs a "five-in-one" full industry chain model, focusing on direct sourcing of authentic medicinal materials to ensure drug quality [1][3] - Future plans include deepening the full industry chain development and innovation, aiming for exponential growth in the Mongolian medicine market through the creation of multiple flagship products [1][2] Company Development - The company has developed a comprehensive system integrating medicinal material cultivation, research and development, production, sales, and modern pharmaceutical logistics [2] - It has established a collaborative innovation system that combines traditional Mongolian medicine with modern medical practices, leveraging academic and research partnerships [2][4] - The company has successfully created a cluster of proprietary insurance products, including 28 varieties covered by national insurance and 14 exclusive products [2][3] Research and Innovation - The company is focused on new drug development and the secondary development of traditional Mongolian medicine, with a strategic plan spanning three five-year phases [4] - It is currently advancing a first-class new drug for treating cerebrovascular diseases, which is in the second phase of research and is expected to be launched in 5-7 years [4] - The company is also working on modernizing Mongolian medicine through evidence-based research and establishing a standardized theoretical framework that is accessible to both Chinese and Western medical experts [4][5] Technological Advancements - The company is leveraging DNA genomics and AI technology to enhance the efficiency of traditional medicine research, potentially reducing the time required to discover effective components from decades to days [5][6] - The company aims to be a pioneer in the transformative changes in traditional medicine research brought about by advancements in AI technology [6]

奥特奇蒙药董事长向公伟: 全产业链布局 推动蒙医药理论标准化 - Reportify